Clinical Trials Browser

Phase 2/3 × Gastrointestinal Neoplasms × Irinotecan × Clear all

NCT04393584 2021-04-13

RusGCG-01

Phase 2/3 Unknown

Gastrointestinal

Gastrointestinal Neoplasms, Stomach Neoplasms